Iveda Solutions Receives Nasdaq Notice for Minimum Bid Price Deficiency

What Happened
Iveda Solutions, Inc. (IVDA) announced on March 6, 2026 that it received a letter from the Nasdaq Listing Qualifications Staff notifying the company that its common stock failed to maintain a minimum $1 per share closing bid price over the last 30 consecutive business days. The company filed this Form 8-K to disclose the notice under Nasdaq Listing Rule 5810(b). The notice does not immediately affect the listing.

Key Details

• Nasdaq found noncompliance with Rule 5550(a)(2) for failing to meet the $1 minimum bid price based on the last 30 consecutive business days.
• The company has a 180-calendar-day compliance period under Rule 5810(c)(3)(A), running through September 2, 2026, to regain compliance.
• To regain compliance, the closing bid price must be at least $1 for a minimum of ten consecutive business days during the cure period.
• If the company does not regain compliance (or fails another listing requirement), Nasdaq may issue a delisting notice; the company could appeal to a Nasdaq Hearings Panel.

Why It Matters
This notice signals a listing compliance risk that could affect liquidity and investor access if the company is eventually delisted. Iveda has until September 2, 2026 to meet the $1 bid threshold (10 consecutive business days) to avoid further Nasdaq action. Investors should monitor the company’s stock price and any follow-up filings for progress toward regaining compliance.